Abstract
Sex differences in cardiac electrophysiology are a crucial factor affecting arrhythmia risk and treatment responses. It is well-documented that females are at a higher risk of drug-induced Torsade de Pointes and sudden cardiac death, largely due to longer QTc intervals compared to males. However, the underrepresentation of females in both basic and clinical research introduces biases that hinder our understanding of sex-specific arrhythmia mechanisms, risk metrics, disease progression, treatment strategies, and outcomes. To address this problem, we developed a quantitative tool that predicts ECG features in females based on data from males (and vice versa) by combining detailed biophysical models of human ventricular excitation-contraction coupling and statistical regression models. We constructed male and female ventricular tissue models incorporating transmural heterogeneity and sex-specific parameterizations and derived pseudo-ECGs from these models. Multivariable lasso regression was employed to generate sets of regression coefficients (a cross-sex translator) that map male ECG features to female ECG features. The predictive ability of the translator was evaluated using an independent dataset that simulates the effects of various drugs and pharmacological agents at different concentrations on male and female models. Furthermore, we demonstrated a proof-of-concept clinical application using ECG data from age-matched subjects of both sexes under various drug regimens. We propose our cross-sex ECG translator as a novel digital health tool that can facilitate sex-specific cardiac safety assessments, ensuring that pharmacotherapy is safe and effective for both sexes, which is a major step forward in addressing disparities in cardiac treatment for females.
One Sentence Summary: We used biophysical and regression models for predicting ECG features across sexes to address disparities in sex-specific cardiac drug responses
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Institute of International Education Quad Fellowship (RS) American Heart Association Career Development Award 24CDA1258695 (HN) American Heart Association Postdoctoral Fellowship 20POST35120462 (HN) NHLBI Grants R01HL131517, R01HL141214, and P01HL141084 (EG) NHLBI Grant R01HL170521 (EG, HN) NHLBI Grants R00HL138160, R01HL171057, and R01HL171586 (SM) National Institute of Aging Grant R03AG086695 (EG) National Institutes of Health Stimulating Peripheral Activity to Relieve Conditions Grant 1OT2OD026580-01 (EG) University of California Davis School of Medicine Dean s Fellow Award (EG) France-Berkeley Fund (EG, JDB)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available human data that were originally located at https://doi.org/10.13026/C2HP45 and https://doi.org/10.13026/C2D016
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All codes are available online at https://doi.org/10.13026/C2HP45
